Log In
BCIQ
Print this Print this
 

CEL-031

  Manage Alerts
Collapse Summary General Information
Company Celek Pharmaceuticals LLC
DescriptionNot disclosed
Molecular Target Phosphodiesterase-2 (PDE-2) ; Phosphodiesterase-5 (PDE-5)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationBladder cancer
Indication DetailsTreat advanced bladder cancer; Treat non-muscle invasive bladder cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today